Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Allist Pharmaceuticals Co Days Payable Chart
SHSE:688578 vs VRTX, REGN, RVMD: Days Payable Comparison
For the Biotechnology subindustry, Shanghai Allist Pharmaceuticals Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai Allist Pharmaceuticals Co Days Payable vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Shanghai Allist Pharmaceuticals Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Shanghai Allist Pharmaceuticals Co's Days Payable falls into.
Shanghai Allist Pharmaceuticals Co Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Allist Pharmaceuticals Co (SHSE:688578) has a Days Payable of 124.97 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Shanghai Allist Pharmaceuticals Co and its competitors. This is 71% below median its historical median of 437.24. Over the past decade, Shanghai Allist Pharmaceuticals Co's Days Payable has ranged from 171.70 to 67,469.80. According to the industry distribution chart, Shanghai Allist Pharmaceuticals Co ranks #284 out of 703 companies in the Biotechnology industry, placing it in the top 40.4%.
Is Shanghai Allist Pharmaceuticals Co's Days Payable too high?
Shanghai Allist Pharmaceuticals Co's current Days Payable of 124.97 is 71% below median its 10-year median of 437.24. Over the past 10 years, this metric has ranged from a low of 171.70 to a high of 67,469.80. The Biotechnology industry median Days Payable is 112.84. Shanghai Allist Pharmaceuticals Co's value of 124.97 is 10.7% above this industry median. Based on the distribution chart, Shanghai Allist Pharmaceuticals Co ranks #284 out of 703 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Shanghai Allist Pharmaceuticals Co has a GF Score™ of 80/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Allist Pharmaceuticals Co's Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Shanghai Allist Pharmaceuticals Co ranks #284 out of 703 companies for Days Payable. This puts Shanghai Allist Pharmaceuticals Co in the upper half of its industry. The industry median Days Payable is 112.84. Shanghai Allist Pharmaceuticals Co's value of 124.97 is 10.7% above this benchmark. Historically, Shanghai Allist Pharmaceuticals Co's own Days Payable has ranged from 171.70 to 67,469.80 over the past decade. While the company's 10-year median is 437.24 vs. the industry median of 112.84, Shanghai Allist Pharmaceuticals Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 112.84, based on 703 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai Allist Pharmaceuticals Co's current Days Payable of 124.97 is 10.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Shanghai Allist Pharmaceuticals Co and its competitors. For the Biotechnology industry, the median Days Payable is 112.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai Allist Pharmaceuticals Co's current Days Payable is 124.97, which is 71% below median its own 10-year median of 437.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Allist Pharmaceuticals Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Allist Pharmaceuticals Co (SHSE:688578) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥135.47, compared to a current price of ¥111.20 — trading 17.9% below its estimated fair value. The current Days Payable is 124.97, which is 71% below median its 10-year median of 437.24 and 10.7% above the Biotechnology industry median of 112.84. Shanghai Allist Pharmaceuticals Co's overall GF Score™ is 80/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Shanghai Allist Pharmaceuticals Co (SHSE:688578), the current Days Payable is 124.97 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai Allist Pharmaceuticals Co (SHSE:688578) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai Allist Pharmaceuticals Co stock appears to be undervalued.
The current stock price of ¥111.20 is trading 17.9% below its estimated GF Value™ of ¥135.47.
GuruFocus considers Shanghai Allist Pharmaceuticals Co to be Modestly Undervalued.
Key valuation signals for SHSE:688578:
Days Payable: 124.97 (71% below median its 10-year median of 437.24)
GF Value™: ¥135.47 vs. price of ¥111.20 (17.9% below fair value)
Industry Position: 10.7% above the Biotechnology median (#284 of 703)
No single metric tells the full story. See the SHSE:688578 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688578 has been successfully added to your 
